Filters
Results 1 - 1 of 1
Results 1 - 1 of 1.
Search took: 0.021 seconds
Happ, J.; Baum, R.P.; Griese, J.; Maul, F.D.; Manegold, K.H.; Nitz, C.; Schwabe, D.; Gerein, V.; Kornhuber, B.; Hoer, G.
Radionuclides for therapy1986
Radionuclides for therapy1986
AbstractAbstract
[en] In treatment of neuroadrenergic tumors with I-131-MIBG, therapeutic success depends on the avidity of the tumor for I-131-MIBG. I-131-MIBG avidity was investigated before therapy and during treatment. Ten patients with neuroblastoma and a patient with metastatic malignant pheochromocytoma received a total of 34 therapeutic doses of MIBG. Repeat diagnostic gamma camera scintigrams were recorded and serial post-treatment scintigrams were obtained after the administration of the therapeutic doses. Tumor/background ratios of I-131 distribution (tumor uptake ratios) were calculated as a measure for I-131-MIBG avidity
Primary Subject
Source
Schubiger, P.A.; Hasler, P.H. (Eidgenoessisches Inst. fuer Reaktorforschung, Wuerenlingen (Switzerland)) (eds.); 244 p; 1986; p. 201-213; Editiones Roche; Basel (Switzerland); Use of radionuclides and vehicles for tumour therapy; Wuerenlingen/Villigen (Switzerland); 13-14 Jun 1986
Record Type
Book
Literature Type
Conference
Country of publication
Reference NumberReference Number
INIS VolumeINIS Volume
INIS IssueINIS Issue